ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $177K invested in Entero Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$118K
2
+$48.3K
3
+$29

Top Sellers

1
-$6.46K
2
-$1.93K
3
-$4
4
US Bancorp
US Bancorp
Minnesota
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$118K
2
$48.3K
3
$10.5K
4
$57
5
$4
6
$4
7
–